- Home
- About
- Section Advisors
- Meet Our Field Medical Affairs Team
- Speakers Bureau
- Supporting Organizations
- Contact Us
- PsychU For You
- Topics
- Mental Health Disorders
- Agitation
- Bipolar Disorder
- Depression
- Pseudobulbar Affect (PBA)
- PTSD/Trauma
- Schizophrenia
- Substance Use Disorders
- Topics of Interest
- Care Coordination
- Digital Health
- Diversity, Equity, & Inclusion
- Health Care Policy, Quality & Payer Administration
- Long-Term Care
- Stigma
- Suicide Awareness
- Wellness
- Events
- Content
- Infographics
- Learning Tracks
- Podcasts
- Shareable/Downloadable Content
- Videos
- PsychUSim
- PsychU Roleplay
- Frameworks In Health & Quality Resources
- Mental Health System Guidebooks
- Psychiatric Scales
- Psychopharmacology
- Supporting Organizations
Spotlight December 2021
Substance Use During The Covid-19 Pandemic
Infographic October 22, 2021PsychU Q&A: What Is The Difference Between Schizophrenia & Schizoaffective Disorder?
Article October 14, 2021Submitted Question: What is the difference between schizophrenia and schizoaffective disorder? Answer: Similarities exist in the presentation, diagnosis and treatment of schizophrenia and schizoaffective disorder that may contribute to the… Read MorePerspectives Of Schizophrenia Treatment Guidelines
On-Demand Webinar October 13, 2021Schizophrenia is a challenging diagnosis both domestically and across the world. Various treatment guidelines have been developed by key thought leaders to share perspectives on acute and long-term management of… Read MoreLong-Acting Injectable Antipsychotics Now Easier To Find Closer To Home
Article August 19, 2021During their 2021 legislative sessions, both Maryland and North Carolina enacted bills to allow pharmacists to administer long-acting injectable antipsychotics (LAIA) and other injectable drugs to consumers with a doctor’s… Read MoreWhat Role Can LAIs Play In Early-Phase Schizophrenia?
Video June 23, 2021Understand the holistic causes of relapse, including thinking and acting long-term, emotional challenges, and adherence and review possible ways to avoid deterioration of functioning, relapse, and rehospitalization. Related Resources Read MoreNeuroimaging Updates In Schizophrenia & The Future Of Precision Medicine: An Interview With Dr. Anissa Abi-Dargham
Video June 15, 2021Dr. Anissa Abi-Dargham will provide updates on the use of neuroimaging in Schizophrenia. She will focus on the recent findings on various neurotransmitter systems including Dopamine, Glutamate, and GABA (gamma… Read MoreDigital Technologies For Schizophrenia
Interview March 22, 2021Dr. Brian Kirkpatrick, MD, MSPH, Chair of Psychiatry and Behavioral Sciences at the University of Nevada, Reno School of Medicine, discusses the role digital technology plays in the treatment of… Read MoreLong-Acting Injectable Antipsychotics & How to Give an Intramuscular Injection
Video July 12, 2019In an effort to support the growing number of professionals and diverse care settings where patients are able to receive a long-acting injectable (LAI) antipsychotic medication, nurse practitioners from the… Read MoreLong-Acting Injectable Antipsychotic Screening, Utilization, & Effects: The RUHS Medical Center Case Study
Video February 18, 2019Riverside University Health System (RUHS) is an academic, tertiary care medical center and county safety-net facility operating a 77 bed inpatient psychiatric hospital located in Riverside, California. In this short… Read MoreStay Connected: